Navigation path

Pharmaceuticals - Community Register


List of refusals for human medicinal products

Milnacipran Pierre Fabre Medicament

Product name: Milnacipran Pierre Fabre Medicament
Active substance: milnacipran
Indication: Treatment of fibromyalgia syndrome
Marketing Authorisation Holder: Pierre Fabre Médicament

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/04/2010 Centralised - Refusal of marketing authorisation EMEA/H/C/1034 (2010)2375 of 8/04/2010